OCULIS HOLDING AG
OCS·H5870P102·US·Common Stock·Healthcare - Biotechnology-13D/G
OCS (OCULIS HOLDING AG) is held by 32 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($46.5M), WELLINGTON MANAGEMENT GROUP LLP ($35.8M), MILLENNIUM MANAGEMENT LLC ($24.3M). Net institutional sentiment: Bullish.
32
Holders
Avg rating(2 Elite)
$170.9M
Total Value
76% (35)
Fund Consensus
22 buying - 7 selling
Who's Trading
ActivistL7LSP 7 Cooperatieve U.A.11.8%Apr 29, 2026
ActivistBIBVCF IV, L.P.4.1%Mar 27, 2026
ActivistNFNan Fung Group Holdings Limited4.9%Nov 14, 2025
13F: Insider & Congress:
Showing 1-20 of 35
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer